Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study M AlJumah, R Bunyan, H Al Otaibi, G Al Towaijri, A Karim, Y Al Malik, ... BMC neurology 20, 1-7, 2020 | 93 | 2020 |
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines B Yamout, M Sahraian, S Bohlega, M Al-Jumah, R Goueider, M Dahdaleh, ... Multiple sclerosis and related disorders 37, 101459, 2020 | 90 | 2020 |
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223 B Steingo, Y Al Malik, AD Bass, R Berkovich, M Carraro, Ó Fernández, ... Journal of Neurology 267, 3343-3353, 2020 | 42 | 2020 |
Acute brucellosis with a guillain-barre syndrome-like presentation: a case report and literature review A Alanazi, S Al Najjar, J Madkhali, Y Al Malik, A Al-Khalaf, A Alharbi Infectious Disease Reports 13 (1), 1-10, 2021 | 19 | 2021 |
Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis A Alanazi, M Alassiri, D Jawdat, Y Almalik Regenerative Therapy 21, 201-209, 2022 | 18 | 2022 |
Familial aggregation of multiple sclerosis: results from the national registry of the disease in Saudi Arabia M AlJumah, HA Otaibi, G Al Towaijri, A Hassan, A Kareem, M Kalakatawi, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (4 …, 2020 | 15 | 2020 |
Cauda equina syndrome secondary to intravascular lymphoma A Abuzinadah, Y Almalik, MT Shabani-Rad, CH Ho, D George, J Alant, ... Neurology: Clinical Practice 2 (2), 158-161, 2012 | 14 | 2012 |
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia M Al Jumah, A Abulaban, H Aggad, R Al Bunyan, M AlKhawajah, ... Multiple Sclerosis and Related Disorders 51, 102925, 2021 | 13 | 2021 |
Cladribine tablets and relapsing–remitting multiple sclerosis: a pragmatic, narrative review of what physicians need to know M AlJumah, MM Alkhawajah, S Qureshi, I Al-Thubaiti, O Ayoub, ... Neurology and therapy 9, 11-23, 2020 | 12 | 2020 |
Patterns and outcomes of complementary and alternative medicine use among adult patients with multiple sclerosis MA Alnahdi, AK Alsulayhim, AHB Salem, E Masuadi, Y Al Malik Cureus 12 (10), 2020 | 11 | 2020 |
Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry E Shosha, A Al Asmi, E Nasim, J Inshasi, F Abdulla, Y Al Malik, ... Multiple Sclerosis and Related Disorders 38, 101448, 2020 | 10 | 2020 |
Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: a case report MA Alnahdi, SI Aljarba, YM Al Malik Multiple Sclerosis and Related Disorders 41, 102141, 2020 | 9 | 2020 |
Delayed tacrolimus-induced optic neuropathy MA Alnahdi, YM Al Malik Neurosciences Journal 24 (4), 324-326, 2019 | 8 | 2019 |
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia F Alshamrani, H Alnajashi, M AlJumah, M Almuaigel, Y Almalik, ... Multiple Sclerosis and Related Disorders 52, 103004, 2021 | 7 | 2021 |
Family planning for people with multiple sclerosis in Saudi Arabia: an expert consensus M Al Jumah, Y Al Malik, NM AlKhawajah, J Saeedi, I AlThubaiti, ... Multiple sclerosis international 2021, 2021 | 7 | 2021 |
Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD) E Shosha, SA Aljarallah, N Al Fugham, AH Al-Jedai, MM Al Luqmani, ... Multiple Sclerosis and Related Disorders 66, 104062, 2022 | 5 | 2022 |
Prevalence of pediatric onset multiple sclerosis in Saudi Arabia R Bunyan, G Al Towaijri, H Al Otaibi, A Kareem, H Algahtani, M Al Mejally, ... Multiple Sclerosis International 2021, 2021 | 5 | 2021 |
The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: A cross-sectional multicentered study AM Alswat, BA Altirkistani, AR Alserihi, OK Baeshen, ES Alrushid, ... Frontiers in Psychiatry 14, 1195101, 2023 | 4 | 2023 |
Economic evaluation of Cladribine tablets in patients with high disease activity–relapsing-remitting multiple sclerosis in the Kingdom of Saudi Arabia S Bohlega, A Elboghdady, A Al-Johani, K Mahajan, MK Mughari, ... Value in Health Regional Issues 25, 189-195, 2021 | 4 | 2021 |
Isolated neurosarcoidosis mimicking multiple sclerosis YM Al Malik Neurosciences Journal 25 (5), 406-411, 2020 | 4 | 2020 |